Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,350 shares at $754.39 ($1.8M) on 2022-11-01, disclosed to the SEC on 2022-11-02.
Open-market sale of $1.8M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $751.24 | 1,518 | $1.1M | 64.4% |
| 2 | $750.00 | 1 | $750 | 0.0% |
| 3 | $753.23 | 40 | $30K | 1.7% |
| 4 | $754.39 | 80 | $60K | 3.4% |
| 5 | $754.39 | 80 | $60K | 3.4% |
| 6 | $755.46 | 81 |
| $61K |
| 3.5% |
| 7 | $755.46 | 81 | $61K | 3.5% |
| 8 | $758.20 | 42 | $32K | 1.8% |
| 9 | $759.39 | 70 | $53K | 3.0% |
| 10 | $759.39 | 70 | $53K | 3.0% |
| 11 | $760.90 | 13 | $10K | 0.6% |
| 12 | $761.36 | 119 | $91K | 5.1% |
| 13 | $761.36 | 119 | $91K | 5.1% |
| 14 | $762.92 | 17 | $13K | 0.7% |
| 15 | $763.10 | 19 | $14K | 0.8% |
| Total | $753.65 avg | 2,350 | $1.8M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |